CN107042092A - Affine sorbing material based on specific recognition c Myc label single domain heavy chain antibodies - Google Patents
Affine sorbing material based on specific recognition c Myc label single domain heavy chain antibodies Download PDFInfo
- Publication number
- CN107042092A CN107042092A CN201710100769.4A CN201710100769A CN107042092A CN 107042092 A CN107042092 A CN 107042092A CN 201710100769 A CN201710100769 A CN 201710100769A CN 107042092 A CN107042092 A CN 107042092A
- Authority
- CN
- China
- Prior art keywords
- myc
- heavy chain
- single domain
- cys
- affine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/24—Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/22—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the construction of the column
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
Abstract
The invention belongs to genetic engineering field, specially the single domain heavy chain antibody (also known as nano antibody) for c Myc labels, it has the amino acid sequence shown in SEQ ID NO.1.Amino acid sequence provided by the present invention can be used as precursor, transformed by random or site-directed mutagenesis technique, result in property (compatibility, specificity, stability etc.) preferably mutant, the nano antibody of the high specific can be purified as the affine in immunity sorbing material for c Myc to the recombinant protein containing c Myc labels.
Description
Technical field
It is special the present invention relates to a kind of affine in immunity sorbing material based on single domain heavy chain antibody (also known as nano antibody technology)
It is not the affine in immunity sorbing material for c-Myc labels.
Technical background
The discovery of c-Myc label proteins comes from Evan in 1985 and has prepared one plant for people's Oncoprotein Myc
The monoclonal antibody 9E10 of albumen, hereafter research finds that the epitope of antibody identification is made up of 10 amino acid residues, its sequence
For Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu, and this 10 amino acid and other protein fusion expressions
Very strong antigen active can be still kept afterwards, can be recognized by corresponding antibodies, and do not influenceed by albumen framework.Cause
This, c-Myc tag systems are widely used in the fields such as immunology detection, cell imaging, affinity purification and protein engineering.
The technologies such as immunoaffinity chromatography, affine in immunity magnetic bead and co-immunoprecipitation are usually used in isolating and purifying containing c-Myc marks
Sign fusion protein.The principle that this kind of affinity purification technology is specifically bound based on aglucon and c-Myc labels, usually, will be special
Property combination c-Myc labels aglucon and carrier conjugation or absorption, be subsequently used for the specific adsorption c-Myc tag fusions from solution
Albumen.
In the market is directed to the affinity column and affine magnetic bead of c-Myc tag fusion protein purifying, and the aglucon of coupling is mostly
Monoclonal antibody or polyclonal antibody.Research and development of monoclonal antibody and production process is relatively complicated and complexity, polyclonal antibody comes
Source is limited.The existing affinity column purified for c-Myc tag fusion proteins and affine magnetic bead price are generally higher.And nanometer is anti-
Body can in Escherichia coli, yeast etc. are biological great expression, advantageously reduce the production cost of correlated product.
Need to use acid in protein purification procedures or alkaline solution is eluted to destination protein.Due to monoclonal antibody or
Polyclonal antibody is made up of heavy chain and light chain, and soda acid elution inevitably can cause antibody activity to reduce, thus can not repeat
Use.By contrast, single domain heavy chain antibody is only made up of a domain, with acid and alkali-resistance, high temperature resistant.There is provided in the present invention
Affine sorbing material, which can be repeated several times, to be used.
The content of the invention
It is an object of the invention to provide a kind of affine in immunity sorbing material for c-Myc labels and its application.
To achieve the above object, the present invention is adopted the following technical scheme that:
Include carrier and aglucon for the affine in immunity sorbing material of c-Myc labels, the aglucon is single domain heavy chain antibody,
With SEQ ID NO.:Amino acid sequence shown in 1.The aglucon can specific recognition c-Myc labels.
The aglucon can also be to be changed on the basis of foregoing single domain heavy chain antibody by random or site-directed mutagenesis technique
Make the antibody that can be specifically bound with c-Myc labels obtained.
The carrier is magnetic bead, agarose gel microsphere, silica gel microball or porous material.
The preparation method of above-mentioned c-Myc labels affine in immunity sorbing material, it is characterized in that:
When the carrier is magnetic bead, preparation method is:1mg carboxyl magnetic beads are taken in centrifuge tube, 600~1000 μ l is added and lives
Change buffer solution (10mM, NaH2PO4, pH 6.0), vortex mixed is uniform, and magnetic frame reclaims magnetic bead, then washs 2 with activation buffer
Time.It is separately added into after 1~5mg carbodiimides (EDC) and n-hydroxysuccinimide (NHS), vortex mixed, stands 35min.With
Coupling buffer (10mM, Na2HPO4, pH 7.4) and wash magnetic bead 5 times, anti-c-Myc labels single domain heavy chain antibody is added, room temperature is anti-
3~5h is answered, the immunomagnetic beads of the anti-c-Myc labels single domain heavy chain antibody of covalent coupling is obtained;
When the carrier is agarose gel microsphere, preparation method is:The dry glue that CNBr is activated is washed with 0.1M HCl
10~20 times, 6~10min is balanced every time.Washed 5~20 times, added with coupling buffer (10mM, Na2HPO4, pH 7.2)
Anti- c-Myc labels single domain heavy chain antibody, reacts at room temperature 3~10h, obtains the anti-c-Myc labels single domain heavy chain antibody of covalent coupling
Affine in immunity sorbing material;
When the carrier is silica gel microball, preparation method is:By silica gel microball pure water and phosphate buffer (PBS,
10mM, pH 6.5) alternately washing 5~15 times, with PBS suspension silica gel microball, add anti-c-Myc labels single domain heavy chain and resist
Body, is mixed, and adds 1~10mg/ml of final concentration carbodiimide (EDC), and rapid to mix, 4 DEG C of 12~20h of stirring reaction are obtained
The covalent coupling affine in immunity sorbing material of anti-c-Myc labels single domain heavy chain antibody.
Above-mentioned affine in immunity sorbing material (carrier is agarose gel microsphere and silica gel microball) is filled to chromatographic column, i.e.,
C-Myc label immune affinity chromatographic columns are obtained, method is:According to chromatography column capacity, appropriate above-mentioned affine in immunity sorbing material is taken
In after chromatographic column, PBS (10 mM, the pH 7.2) washings for adding 8~10 times of bed volumes, 4 DEG C, 20% ethanol solution is stored in.
The invention further relates to be mounted with the affinity column of c-Myc labels affine in immunity sorbing material described in claim 1.
The application of above-mentioned c-Myc labels affine in immunity sorbing material, with the c-Myc labels affine in immunity sorbing material pair
The albumen of the label containing c-Myc is purified in sample.When the carrier of immune absorption material is that agarose gel microsphere and silica gel are micro-
During ball, method is:Immune absorption material is washed with PBS (10mM, pH 7.2) first, sample extracting solution is added, then uses pure water
Elution, then with glycine hydrochloride (pH 2.2) elute specific adsorption the recombinant protein of label containing c-Myc, the eluent of collection,
Sample extracting solution after purification, available for subsequent analysis detection.When carrier is magnetic bead, method is:Immunomagnetic beads is added pure
In water, magnetic frame reclaims magnetic bead, and then immunomagnetic beads is added in sample extracting solution, mixed, magnetic frame by repeated washing 3~5 times
Magnetic bead is reclaimed, after pure water is cleaned 3~5 times, the c-Myc labels for eluting specific adsorption with glycine hydrochloride (pH 2.2) recombinate egg
In vain, the eluent of collection, is sample extracting solution after purification, available for subsequent analysis detection.
The present invention is single domain heavy chain antibody for the affine in immunity sorbing material aglucon of c-Myc labels, with SEQ ID
NO.:Amino acid sequence shown in 1, the aglucon can specific recognition c-Myc labels.The single domain heavy chain antibody is readily available, resistance to
Heat, it is single domain heavy chain antibody that aglucon can be produced by biological method mass propgation, it is to avoid the cumbersome production such as artificial antibody
Method, greatly reduces production cost, and reusable, has a extensive future.
Embodiment
Below by the preparation and application of c-Myc label affine in immunity sorbing materials, the present invention will be further described, this
A little specific embodiments are not construed in any way as limiting the application of the present invention.
Embodiment 1:
The structure of anti-c-Myc labels single domain heavy chain antibody (i.e. for the single domain heavy chain antibody of c-Myc labels) non-immune libraries
By c-Myc labels and bovine serum albumin(BSA) (Bovine serum albumin, BSA) covalent coupling, c-Myc is obtained
Artificial antigen c-Myc-BSA, takes 300 μ g c-Myc-BSA with after Freund's complete adjuvant emulsification, entering to alpaca (Lama pacos)
The subcutaneous multi-point injection of row is immunized.Booster immunization is emulsified using 150 μ g c-Myc-BSA with incomplete Freund's adjuvant, and interval is entered for 2 weeks
OK, venous blood sampling after being immunized 7 days every time, serum titer, selection serum titer highest sample point are determined using indirect elisa method
From lymphocyte, RNA is extracted.
RNA extraction is carried out with reference to TAKARA company RNAiso reagents specification.Using RNA as template, oligo dT are to draw
Thing, with reference to the TAKARA companies reverse transcriptase specification synthesis chains of cDNA first.
Using PrimeSTAR high-fidelity DNA polymerases, the variable region encoding gene for obtaining heavy chain antibody through nest-type PRC (is adopted
1) primer is shown in Table.First round PCR expands cDNA with primer AlpVh-LD and CH2-R respectively, and reaction condition is, 98 DEG C,
10s, 55 DEG C, 20s, 72 DEG C, 1min, 20 circulations, 98 DEG C, 10s, 68 DEG C, 1min, 72 DEG C of extension 10min.
By first round PCR primer with 1.2% agarose gel electrophoresis, 600bp~750bp DNA fragmentation is reclaimed, is made
For second wheel PCR template, respectively with primer AlpVh-SfiI and AlpVHHR1-NotI, AlpVh-SfiI and AlpVHHR2-
NotI, is expanded, and reaction condition is, 98 DEG C, 10s, 50 DEG C, 20s, 72 DEG C, 40s, 5 circulations, 98 DEG C, 10s, 68 DEG C,
40s, 30 circulations, 72 DEG C of extension 10min.Reclaim, quantify through DNA fragmentation QIAquick Gel Extraction Kit, saved backup in -20 DEG C.It will bite
Bacterium grain pHEN1 and pcr amplification product use Sfi I, Not I double digestions respectively, reclaimed through Ago-Gel, it is quantitative after, with 1: 3
Mol ratio, at 16 DEG C, is connected overnight.
The library construction of table 1 and identification primer used
Note:Underscore represents restriction endonuclease recognition sequence
Connection product is dissolved in 10 μ L sterilized waters after ethanol precipitation, and Electroporation Transformation e. coli tg1 is carried out in ten times.
The bacterium solution doubling dilution after 10 μ L electric shocks, culture is taken, ampicillin 2 × YT culture plates are coated with, storage capacity is calculated.Remainder
24cm × 24cm ampicillin 2 × YT culture plates are all coated on, 37 DEG C, 13~16h of culture are inverted.Trained with 10mL, 2 × YT
After foster base scrapes the lawn on culture plate, the glycerine of final concentration 20~30% is added, is dispensed, -80 DEG C save backup.
According to the storage capacity result of calculating, the living cells for being inoculated with 10 times of storage capacities (contains 2% grape in 20mL 2 × YT
Sugar, 100 μ g/mL ampicillins), 37 DEG C, 200r/min is cultivated to OD600Up to 0.5, add auxiliary by infection multiplicity 20: 1 and bite
Thalline, 37 DEG C, 200r/min, 60 min.Culture is centrifuged, (contains 100 μ g/mL ampicillins and 50 with 50mL 2 × YT
μ g/mL kanamycins) precipitation is resuspended, 37 DEG C, after 200r/min incubated overnights, 8000rpm centrifuging and taking supernatants add 5 × PEG/
NaCl solution, places 1.5h or 4 DEG C overnight on ice, and 8000rpm centrifugation 30min, resuspension is deposited in the phosphoric acid containing 10% glycerine and delayed
Fliud flushing (PBS, 0.01M, pH 7.4), that is, obtain anti-c-Myc labels single domain heavy chain antibody non-immune libraries, takes 10 μ L to determine titre,
Remaining is sub-packed in -80 DEG C and saved backup.
Embodiment 2:
The elutriation and identification of anti-c-Myc labels single domain heavy chain antibody
Using the method for the affine elutriation of solid phase from the anti-c-Myc labels single domain heavy chain antibody non-immune libraries of the gained of embodiment 1
Elutriation is directed to the single domain heavy chain antibody of c-Myc labels.The Myc-GST that 120 μ L PBS dilute is added into each enzyme mark hole to melt
Hop protein (albumen that Myc labels are merged with glutathione), 4 DEG C, coating is stayed overnight, and the coating concentration for often taking turns elutriation is respectively
100,75,50 μ g/mL;Coating buffer is suctioned out, PBS board-washings 5 times add 300 μ L 3%BSA-PBS per hole, 37 DEG C, close 2h;PBS
Board-washing 5 times, adds 100 μ L phage antibody libraries (containing about 1 × 1011CFU), 37 DEG C, it is incubated 2.0h;Suction out uncombined phagocytosis
Body, with PBST (contain 0.5%Tween-20) board-washing 3-5 time (increasing by 5 times by wheel), then with PBS board-washings 15-25 times;With 100 μ L
Bacteriophage of eluent (glycine-HCI, pH 2.2) the elution absorption in enzyme mark hole, with 35 μ L Tris-HCl (1 mol/L,
PH 8.0) eluate is neutralized, take 10 μ L to be used for titer determination, be used for next round elutriation after the amplification of remaining 125 μ L eluate.
After four-wheel elutriation, the monoclonal of random picking is rescued using helper phage KM13, exhibition is respectively obtained
Show the phage particle of antibody variable region, then determine with indirect phage-ELISA the binding activity and specificity of phage particle,
Experiment setting control, specific load procedure is shown in Table 2.
The indirect phage-ELISA of table 2 is loaded table
Send biotechnology service company to carry out sequencing ELISA positive colonies, obtain the DNA sequence dna of Insert Fragment,
It encodes the single domain heavy chain antibody for c-Myc labels.
DNA sequence dna (SEQ ID NO.:2):
CAGTTGCAGCTCGTGGAGTCAGGGGGAGGCTTGGTGCAGCCTGGGGGGTCTCTG
ACGCTCTCCTGTCTAGCCTCTGGATTCACTCTTAGTAACTACTACATGAGCTGGGTCCG
CCAGGCTCCAGGAAAGGGGCCCGAGTGGGTCGCGGAGGTTAATGATAGTGGCTTTGG
CAGAAACTATGGAGACTCCGTGAAGGGCCGATTCACCATCTCTAGAGACAACGCCAAG
AGCACGGTATACTTGGAAATGAATGACCTGAAACCTGAGGACACGGCCCTATATTACTG
TGCGCGCGATCGGTATCTTGACCTCAGAGAGTATGATTACTGGGGCCAGGGGACCCAG GTCACCGTCTCCTCA
Coding has SEQ ID NO.:Amino acid sequence shown in 1:
QLQLVESGGGLVQPGGSLTLSCLASGFTLSNYYMSWVRQAPGKGPEWVAEVNDSGF
GRNYGDSVKGRFTISRDNAKSTVYLEMNDLKPEDTALYYCARDRYLDLREYDYWGQGT QVTVSS。
Embodiment 3:
It is prepared by the scale of anti-c-Myc labels single domain heavy chain antibody
Encode the acquisition of the DNA fragmentation of anti-c-Myc labels single domain heavy chain antibody:1. using restriction enzyme SfiI/
NotI, double digestion phasmid pHEN-anti-c-Myc single domain heavy chain antibody genes, agarose gel electrophoresis reclaims anti-c-Myc marks
Sign a bill domain heavy chain antibody genes;2. directly send biotechnology service company by anti-c-Myc labels single domain heavy chain antibody coded sequence
Carry out chemical synthesis;3. expand in designing specific primer, the cDNA storehouses originated by round pcr from alpaca (Lama pacos)
Increase.
Obtained anti-c-Myc tags single domain heavy chain antibody genes fragment is cloned into expression vector pET25-flag
(by carrier, institute band c-Myc tag replacements are Flag labels in itself:DYKDDDDK), identified through PCR and digestion, build and complete anti-
The colibacillus expression plasmid of c-Myc label single domain heavy chain antibodies.
Expression plasmid is converted to Escherichia coli rosetta, picking single bacterium colony carries out induced expression.Single bacterium colony is accessed
In 5mL LB-A (the μ g/mL ampicillin of Luria-Bertani broth with 100) fluid nutrient medium, 37 DEG C, 220r/
Min shaken cultivations 12h;It is transferred to the inoculum concentration of 1% culture volume in 50mL LB-A fluid nutrient mediums, 37 DEG C,
220r/min shaken cultivations are to OD6000.5 (about needing 3~3.5h) is reached, final concentration 0.1mM IPTG, 30 DEG C, 200r/ is added
Min Fiber differentiations.
Induced cultures 8000r/min is centrifuged, and 25mL phosphate buffers (pH 7.4) are added in cell precipitation and are mixed,
8000r/min is centrifuged, and removes supernatant, retains cell precipitation;15mL same buffers are added in cell precipitation, mixes, surpasses on ice
Sound wave clasmatosis is handled, and ultrasonication condition is 200W, crushes 2s, interval 5s, totally 250 circulations, broken to cell at 4 DEG C
The 8000r/min that minces centrifuges 15min, takes supernatant to carry out affinitive layer purification and SDS-PAGE electrophoretic analysis, or add in supernatant
Enter the glycerine of final concentration 20%, mix, be stored in -20 DEG C of refrigerator-freezers stand-by.
By optimizing induced expression condition (such as Host Strains, expression vector, Fiber differentiation time, temperature and IPTG concentration
Deng), destination protein (single domain heavy chain antibody) expression quantity can be further improved, is largely to prepare anti-c-Myc labels single domain heavy chain
Antibody provides approach.
The amalgamation and expression of anti-c-Myc labels single domain heavy chain antibody:
Anti- c-Myc labels single domain heavy chain antibody genes of the invention are cloned into fusion expression vector pAP (containing alkaline phosphatase
Enzyme gene), identified through PCR and digestion, build the alkaline phosphatase fusion expression matter for completing anti-c-Myc labels single domain heavy chain antibody
Grain.
Alkaline phosphatase can non-specific catalytic phosphatase monoesters hydrolysis generation inorganic phosphate and corresponding alcohol, phenol or carbohydrate
Compound.The enzyme is used for the detection methods such as ELISA, Western blotting, histochemistry frequently as signal element.Fusion expression plasmid will
Anti- c-Myc labels single domain heavy chain antibody is blended in the N-terminal of alkaline phosphatase, with reference to the expression in application example 3, Ke Yi
Expression in escherichia coli, it is purified into fusion protein AP-anti-c-Myc label single domain heavy chain antibodies.
The heat-resistant experiment of the nano antibody of anti-c-Myc labels
Nano antibody heat endurance is measured by ELISA experiments, experimental method is as follows:
It is 5 μ g/mL Myc-GST albumen to take concentration, is added with every μ L of hole 100 in 96 hole elisa Plates, 4 DEG C of coatings are stayed overnight;
0.05%PBST board-washings 3 times;3% 37 DEG C of closing lh of skim milk;The c-Myc nano antibodies added after dilution, per the μ of hole 100
L, is incubated 1h by 37 DEG C;Add 1:The anti-His labels secondary antibody of 2000 working concentration HRP marks, 100 μ L are added per hole, 37 DEG C, are incubated
Educate 1h;TMB nitrite ions are added, 100 μ L are added per hole;30min is incubated at a temperature of in multigroup difference;After reaction terminates, add
2M sulfuric acid terminating reactions, 50 μ L are added per hole, mix and 450nm light absorption values are determined after terminating reaction.
Even if as a result display temperature is up to 70 DEG C, 80 DEG C, 90 DEG C, protein active still has bioactivity, OD450Value point
Not Wei 1.4,1.3,1.2, with preferable heat resistance.
Embodiment 4:
A small amount of preparations of c-Myc label affine in immunity magnetic beads
Using nanometer magnetic bead as carrier, it is coupled after anti-c-Myc labels single domain heavy chain antibody, obtains c-Myc labels and be immunized
Magnetic bead, specific preparation method is as follows:
The magnetic bead of 1mg carboxyl modifieds is taken in centrifuge tube, 500 μ l activation buffers (10mM, NaH are added2PO4, pH
6.0), vortex mixed is uniform, and magnetic frame reclaims magnetic bead, then is washed 3 times with activation buffer.It is separately added into 2mg carbodiimides
(EDC) and n-hydroxysuccinimide (NHS), after vortex mixed, 25min is stood.With coupling buffer (10mM, Na2HPO4, pH
7.4) washing magnetic bead 3 times, adds the anti-c-Myc labels single domain heavy chain antibody 1mg for being dissolved in coupling buffer, reacts at room temperature 3.5h,
Magnetic bead is washed with coupling buffer 5 times, add 500 μ l and contain 1% (w/v) bovine serum albumin(BSA) (BSA) or 1% (w/v) egg white egg
The coupling buffer of (OVA) closes unreacted active group in vain, reacts at room temperature 35min.Magnetic bead 5 is washed with coupling buffer
It is secondary, PBS solution (10mM, pH 7.2,0.02%w/v, Na3N 4 DEG C are stored in after) being resuspended.
Embodiment 5:
The preparation of c-Myc label affine in immunity sorbing materials and affinity column
Using agarose microbeads as carrier, anti-c-Myc labels single domain heavy chain antibody is coupled, specific preparation method is as follows:
The dry glue that CNBr is activated is washed 10 times with 0.1M HCl, and 5min is balanced every time.With coupling buffer (10mM,
Na2HPO4, pH 7.2) wash 10 times, anti-c-Myc labels single domain heavy chain antibody (every gram of agarose microbeads of 2mg/) is added, room temperature is anti-
3.5h is answered, the agarose gel microsphere covalent coupling for making anti-c-Myc labels single domain heavy chain antibody be activated with CNBr.With coupling buffering
Liquid (10mM, Na2HPO4, pH 7.2) and after washing 3 times, confining liquid room temperature reaction 2.5h is added to close unreacted active group
Group.The phosphate buffer (10mM, pH 7.2) and acetate buffer solution (0.1M, pH 4.5) accumulated with 6 times of colloids alternately washing 3 times,
Obtain the affine in immunity sorbing material of the anti-c-Myc labels single domain heavy chain antibody of covalent coupling.The above-mentioned affine in immunities of 0.2ml are taken to inhale
Enclosure material adds 20% second in after the chromatographic column that capacity is 1 ml, PBS (10mM, the pH 7.2) washings of 8~10 times of bed volumes
Alcoholic solution, 4 DEG C of preservations.
Embodiment 6:
The preparation of c-Myc label affine in immunity sorbing materials and affinity column
Using silica gel microball as carrier, anti-c-Myc labels single domain heavy chain antibody is coupled, specific preparation method is as follows:
Alternately washing 6~10 times of 2g silica gel microballs pure water and phosphate buffer (PBS, 10mM, pH 6.5) are taken, 10ml is used
PBS suspension silica gel microball, adds the anti-c-Myc labels single domain heavy chain antibodies of 5mg, mixes, and adds final concentration 5mg/ml's
Carbodiimide (EDC), rapid to mix, 4 DEG C of 12~20h of stirring reaction obtain the anti-c-Myc labels single domain heavy chain of covalent coupling
The affine in immunity sorbing material of antibody.The above-mentioned affine in immunity sorbing materials of 0.2ml are taken in the chromatographic column that capacity is 1ml, 58~10
After PBS (10mM, the pH 6.5) washings of times bed volume, add and contain 0.02% (w/v) Na3N PBS (10mM, pH 6.5), 4
DEG C preserve.
Embodiment 7:
The adsorbance of c-Myc label affinity columns, reuse are determined
Pillars are cleaned with 6 times of bed volume PBS (10mM, pH 7.2), protein sample solution is added, efflux mistake again
Post.Then eluted with 3 times of bed volume pure water, then being marked containing c-Myc for specific adsorption is eluted with glycine hydrochloride (pH 2.2)
Recombinant protein is signed, the eluent of collection is protein solution after purification.Test result indicates that, be filled with 1mL embodiments 5,6,
7 affinity column/the magnetic beads prepared can be with specific adsorption destination protein.After reusing 10 times, the rate of recovery is still above 80%.
It is single domain heavy chain antibody that aglucon can be produced by biological method mass propgation, it is to avoid the cumbersome producer such as artificial antibody
Method, greatly reduces production cost, and reusable, has a extensive future.
SEQUENCE LISTING
<110>University Of Nanchang
<120>Affine sorbing material based on specific recognition c-Myc label single domain heavy chain antibodies
<130> 2017
<160> 9
<170> PatentIn version 3.3
<210> 1
<211> 360
<212> PRT
<213>Artificial sequence
<400> 1
Cys Ala Gly Thr Thr Gly Cys Ala Gly Cys Thr Cys Gly Thr Gly Gly
1 5 10 15
Ala Gly Thr Cys Ala Gly Gly Gly Gly Gly Ala Gly Gly Cys Thr Thr
20 25 30
Gly Gly Thr Gly Cys Ala Gly Cys Cys Thr Gly Gly Gly Gly Gly Gly
35 40 45
Thr Cys Thr Cys Thr Gly Ala Cys Gly Cys Thr Cys Thr Cys Cys Thr
50 55 60
Gly Thr Cys Thr Ala Gly Cys Cys Thr Cys Thr Gly Gly Ala Thr Thr
65 70 75 80
Cys Ala Cys Thr Cys Thr Thr Ala Gly Thr Ala Ala Cys Thr Ala Cys
85 90 95
Thr Ala Cys Ala Thr Gly Ala Gly Cys Thr Gly Gly Gly Thr Cys Cys
100 105 110
Gly Cys Cys Ala Gly Gly Cys Thr Cys Cys Ala Gly Gly Ala Ala Ala
115 120 125
Gly Gly Gly Gly Cys Cys Cys Gly Ala Gly Thr Gly Gly Gly Thr Cys
130 135 140
Gly Cys Gly Gly Ala Gly Gly Thr Thr Ala Ala Thr Gly Ala Thr Ala
145 150 155 160
Gly Thr Gly Gly Cys Thr Thr Thr Gly Gly Cys Ala Gly Ala Ala Ala
165 170 175
Cys Thr Ala Thr Gly Gly Ala Gly Ala Cys Thr Cys Cys Gly Thr Gly
180 185 190
Ala Ala Gly Gly Gly Cys Cys Gly Ala Thr Thr Cys Ala Cys Cys Ala
195 200 205
Thr Cys Thr Cys Thr Ala Gly Ala Gly Ala Cys Ala Ala Cys Gly Cys
210 215 220
Cys Ala Ala Gly Ala Gly Cys Ala Cys Gly Gly Thr Ala Thr Ala Cys
225 230 235 240
Thr Thr Gly Gly Ala Ala Ala Thr Gly Ala Ala Thr Gly Ala Cys Cys
245 250 255
Thr Gly Ala Ala Ala Cys Cys Thr Gly Ala Gly Gly Ala Cys Ala Cys
260 265 270
Gly Gly Cys Cys Cys Thr Ala Thr Ala Thr Thr Ala Cys Thr Gly Thr
275 280 285
Gly Cys Gly Cys Gly Cys Gly Ala Thr Cys Gly Gly Thr Ala Thr Cys
290 295 300
Thr Thr Gly Ala Cys Cys Thr Cys Ala Gly Ala Gly Ala Gly Thr Ala
305 310 315 320
Thr Gly Ala Thr Thr Ala Cys Thr Gly Gly Gly Gly Cys Cys Ala Gly
325 330 335
Gly Gly Gly Ala Cys Cys Cys Ala Gly Gly Thr Cys Ala Cys Cys Gly
340 345 350
Thr Cys Thr Cys Cys Thr Cys Ala
355 360
<210> 2
<211> 381
<212> DNA
<213> Lama pacos
<400> 2
cagttgcagc tcgtggagtc agggggaggc tcggtgcagc ctggggggtc tctaacactc 60
tcctgctcag cctctggatt caatatatca caatattccg tggggtggtt ccgcgaggcc 120
ccaggggaag agcgtgaggg gatctcatgt ctggacattg atggcaaaat taccaccttc 180
tcagacgcca tacagggccg attcaccatc gcccgagaca atgctgcaaa tatgatatac 240
ttacacatgg acgccctgaa ccctctggat acggccgttt atcggtgtgt cgccagatgg 300
gactgttcgc gacacgattt tatcacccag aaaaccgcta ccggcatctg gggcccgggg 360
acccaggtca ccgtgtcagc a 381
<210> 3
<211> 18
<212> DNA
<213>Artificial sequence
<400> 3
cttggtggtc ctggctgc 18
<210> 4
<211> 49
<212> DNA
<213>Artificial sequence
<220>
<221> misc_feature
<222> (44)..(44)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (47)..(47)
<223> n is a, c, g, or t
<400> 4
tcgcggccca gccggccatg gcccagktgc agctcgtgga gtcnggngg 49
<210> 5
<211> 33
<212> DNA
<213>Artificial sequence
<400> 5
cgagtgcggc cgcggggtct tcgctgtggt gcg 33
<210> 6
<211> 34
<212> DNA
<213>Artificial sequence
<400> 6
cgagtgcggc cgcttgtggt tttggtgtct tggg 34
<210> 7
<211> 23
<212> DNA
<213>Artificial sequence
<400> 7
ggtacgtgct gttgaactgt tcc 23
<210> 8
<211> 24
<212> DNA
<213>Artificial sequence
<400> 8
agcggataac aatttcacac agga 24
<210> 9
<211> 20
<212> DNA
<213>Artificial sequence
<400> 9
gccccattca gatcctcttc 20
Claims (5)
1. a kind of c-Myc labels affine in immunity sorbing material, including carrier, are mounted in the aglucon on carrier, it is characterised in that should
Material is using the single domain heavy chain antibody of specific recognition c-Myc labels as aglucon, the single domain of the specific recognition c-Myc labels
Heavy chain antibody has SEQ ID NO.:Amino acid sequence shown in 1.
2. c-Myc labels affine in immunity sorbing material according to claim 1, it is characterised in that the aglucon is in SEQ
ID NO.:The energy and c-Myc of house of correction acquisition are carried out on the basis of amino acid sequence shown in 1 by random or site-directed mutagenesis technique
The antibody of label specific binding.
3. c-Myc labels affine in immunity sorbing material according to claim 1, it is characterised in that the carrier is magnetic bead.
4. c-Myc labels affine in immunity sorbing material according to claim 1, it is characterised in that the carrier is agar
Sugared microballoon.
5. c-Myc labels affine in immunity sorbing material according to claim 1, it is characterised in that the carrier is silica gel
Microballoon or porous material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710100769.4A CN107042092A (en) | 2017-02-23 | 2017-02-23 | Affine sorbing material based on specific recognition c Myc label single domain heavy chain antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710100769.4A CN107042092A (en) | 2017-02-23 | 2017-02-23 | Affine sorbing material based on specific recognition c Myc label single domain heavy chain antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107042092A true CN107042092A (en) | 2017-08-15 |
Family
ID=59545445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710100769.4A Pending CN107042092A (en) | 2017-02-23 | 2017-02-23 | Affine sorbing material based on specific recognition c Myc label single domain heavy chain antibodies |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107042092A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108893487A (en) * | 2018-07-19 | 2018-11-27 | 中国农业科学院北京畜牧兽医研究所 | A kind of construction method of plant expression plasmid carrier containing C-Myc protein fusion label and its carrier |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101105493A (en) * | 2007-06-27 | 2008-01-16 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | Method for detecting protein interaction by immunological coprecipitation based on protein chip and reagent kit for detecting protein interaction |
CN101463085A (en) * | 2009-01-16 | 2009-06-24 | 清华大学 | Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
CN102175649A (en) * | 2011-01-04 | 2011-09-07 | 长沙理工大学 | LSPR (Localized Surface Plasmon Resonance) sensing chip for detecting recombinant protein of carcinogene C-myc |
CN103048458A (en) * | 2012-11-29 | 2013-04-17 | 大连大学 | ELISA (enzyme-linked immunosorbent assay) method for quickly testing C-Myc by using monoclonal antibody |
CN103866401A (en) * | 2014-03-28 | 2014-06-18 | 中国农业科学院油料作物研究所 | Aflatoxin nano antibody gene pool, construction method and application of aflatoxin nano antibody gene pool as well as aflatoxin B1 nano antibody 2014AFB-G15 |
CN105396558A (en) * | 2015-12-02 | 2016-03-16 | 南昌大学 | Affinity adsorption material based on anti-AFB1 nanometer antibody |
CN105396559A (en) * | 2015-12-02 | 2016-03-16 | 南昌大学 | Affinity adsorption material based on anti-aflatoxin nanometer antibody |
-
2017
- 2017-02-23 CN CN201710100769.4A patent/CN107042092A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101105493A (en) * | 2007-06-27 | 2008-01-16 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | Method for detecting protein interaction by immunological coprecipitation based on protein chip and reagent kit for detecting protein interaction |
CN101463085A (en) * | 2009-01-16 | 2009-06-24 | 清华大学 | Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
CN102175649A (en) * | 2011-01-04 | 2011-09-07 | 长沙理工大学 | LSPR (Localized Surface Plasmon Resonance) sensing chip for detecting recombinant protein of carcinogene C-myc |
CN103048458A (en) * | 2012-11-29 | 2013-04-17 | 大连大学 | ELISA (enzyme-linked immunosorbent assay) method for quickly testing C-Myc by using monoclonal antibody |
CN103866401A (en) * | 2014-03-28 | 2014-06-18 | 中国农业科学院油料作物研究所 | Aflatoxin nano antibody gene pool, construction method and application of aflatoxin nano antibody gene pool as well as aflatoxin B1 nano antibody 2014AFB-G15 |
CN105396558A (en) * | 2015-12-02 | 2016-03-16 | 南昌大学 | Affinity adsorption material based on anti-AFB1 nanometer antibody |
CN105396559A (en) * | 2015-12-02 | 2016-03-16 | 南昌大学 | Affinity adsorption material based on anti-aflatoxin nanometer antibody |
Non-Patent Citations (2)
Title |
---|
汪世华 等: "《抗体技术》", 31 March 2009, 军事医学科学出版社 * |
许菲: ""抗c-Myc纳米抗体的淘选、表达及应用"", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108893487A (en) * | 2018-07-19 | 2018-11-27 | 中国农业科学院北京畜牧兽医研究所 | A kind of construction method of plant expression plasmid carrier containing C-Myc protein fusion label and its carrier |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107085098A (en) | A kind of aflatoxin nano antibody affine in immunity sorbing material | |
CN105498702A (en) | Immune-affinity adsorbing material based on single-domain heavy chain antibody resisting to aflatoxin | |
CN107042091A (en) | Affine in immunity sorbing material based on specific recognition c Myc label nano antibodies | |
CN105396558A (en) | Affinity adsorption material based on anti-AFB1 nanometer antibody | |
CN105968205B (en) | A kind of nano antibody of anti-prostate-specific membrane antigen | |
CN107042092A (en) | Affine sorbing material based on specific recognition c Myc label single domain heavy chain antibodies | |
CN107042098A (en) | The affine in immunity material of Specific adsorption c Myc label nano antibodies | |
CN107042099A (en) | The affine in immunity material of Specific adsorption c Myc label single domain heavy chain antibodies | |
CN107042090A (en) | Affine in immunity sorbing material based on specific recognition c Myc label single domain heavy chain antibodies | |
CN107051397A (en) | The affine in immunity sorbing material of specific recognition c Myc label nano antibodies | |
CN107081136A (en) | Affine sorbing material based on anti-c Myc labels single domain heavy chain antibody | |
CN106188279A (en) | A kind of nano antibody of the specific recognition immunoglobulin Fc section in immune library source | |
CN107043421A (en) | The single domain heavy chain antibody of anti-c Myc labels | |
CN106946990A (en) | A kind of nano antibody for c Myc labels | |
CN106831991A (en) | The nano antibody of anti-c Myc labels | |
CN106890622A (en) | Affine sorbing material based on anti-c Myc label nano antibodies | |
CN106914229A (en) | Affine sorbing material based on specific recognition c Myc label nano antibodies | |
CN106831990A (en) | A kind of nano antibody that can specifically bind c Myc labels | |
CN106902751A (en) | Affine in immunity sorbing material based on anti-c Myc label nano antibodies | |
CN106902750A (en) | Affine in immunity sorbing material based on anti-c Myc labels single domain heavy chain antibody | |
CN106946992A (en) | For the single domain heavy chain antibody of c Myc labels | |
CN106946991A (en) | The nano antibody of c Myc labels can be specifically bound | |
CN105396557A (en) | Affinity adsorption material based on nanometer antibody capable of specially recognizing aflatoxin | |
CN107011442A (en) | A kind of nano antibody of specific recognition c Myc labels | |
CN106946993A (en) | It is a kind of to specifically bind the single domain heavy chain antibody of c Myc labels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170815 |